1. Report Overview
1.1 Overview of the Pharmaceutical Anti-Counterfeiting Market
1.2 Why You Should Read this Report
1.3 How this Study Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Investigation For?
1.6 Method of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Associated visiongain Reports
1.9 About visiongain
2. Introduction to Pharmaceutical Counterfeiting
2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry in Recent Years
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 The Incidence of Counterfeited Pharmaceuticals is Increasing
2.1.3 Asia and Europe are Counterfeiting Hotspots in 2014
2.2 What are the Most Commonly Counterfeited Drugs?
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.4 Why are Drugs Counterfeited?
2.5 Methods of Producing Pharmaceutical Counterfeits
2.5.1 Moving Counterfeits into the Pharmaceutical Supply Chain
2.5.2 Corruption Within the Pharmaceutical Distribution System
2.6 The Role of the Internet in Pharmaceutical Counterfeiting
2.6.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.6.2 Legal Online Pharmacies: A Convenient and quick Way of Dispensing Medication
2.6.3 Verifying the Authenticity of Online Pharmacies
2.7 The Global Costs of Pharmaceutical Counterfeiting
2.7.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.7.2 The Impact of Counterfeiting on Healthcare Providers
2.7.3 The Impact of Counterfeiting on Pharma Manufacturers
2.7.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.7.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.8 Operation Pangea: Europol’s Fight Against Online Counterfeiting
2.8.1 Legislative Deficiencies Aiding Counterfeiting Operations
2.9 Factors Driving Pharmaceutical Counterfeiting
2.9.1 An Erratic Supply or Shortage of drugs Promotes Counterfeiting
2.9.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.9.3 Drug Misuse Creates a Market for Counterfeiting
2.9.4 Trade Through Free-Trade Zones/Free Ports is an Important Route for Counterfeiters
2.9.5 The Trade of Pharmaceuticals Through Several Intermediaries Helps Hide Counterfeit Drugs
2.9.6 Counterfeiters Target Developed Markets
2.9.7 Parallel Trade – A Counterfeiting Route in Europe
2.10 Leading Anti-Counterfeiting Technologies and Applications
2.10.1 Passive Anti-Counterfeiting Technologies
2.10.2 Active Anti-Counterfeiting Technologies
2.10.3 Mass Encoding Techniques
3. The Global Market for Pharmaceutical Anti-Counterfeiting Technologies, 2016-2026
3.1 World Pharmaceutical Anti-counterfeiting Technologies Market in 2014 and 2015
3.1.1 Breakdown of the World Pharmaceutical Anti-Counterfeiting Market by Technology in 2015
3.2 World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026
3.2.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast, 2014-2020
3.2.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Sales Forecast, 2020-2026
3.3 RFID Leads the World Pharmaceutical Anti-Counterfeiting Technologies Market
3.4 How Will Market Shares Change to 2026?
3.5 Drivers and Restraints for the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
4. The Pharmaceutical Barcodes Market, 2016-2026
4.1 Barcodes as Anti-counterfeiting Technology
4.2 Pharmaceutical Barcodes Submarket in 2014 and 2015
4.3 Pharmaceutical Barcodes Market: Sales Forecast 2016-2026
4.4 Pharmaceutical Barcodes Market: Drivers and Restraints, 2016-2026
5. The Pharmaceutical RFID Submarket 2016-2026
5.1 RFID as Anti-counterfeiting Technology
5.2 Pharmaceutical RFID Market in 2014 and 2015
5.3 Pharmaceutical RFID Market: Sales Forecast 2016-2026
5.4 Pharmaceutical RFID Submarket: Drivers and Restraints 2016-2026
5.4.1 Drivers of the of the Pharmaceutical RFID Submarket
5.4.2 Restraints of the Pharmaceutical RFID Submarket
6. Pharmaceutical Taggants Submarket 2016-2026
6.1 Taggants as Anti-counterfeiting Technology
6.2 Pharmaceutical Taggants Submarket in 2014 and 2015
6.3 Pharmaceutical Taggants Market: Sales Forecast 2016-2026
6.4 Pharmaceutical Taggants Market: Drivers and Restraints 2016-2026
7. Pharmaceutical Holograms/OVD Market 2016-2026
7.1 Holograms as Anti-Counterfeiting Technology
7.2 Pharmaceutical Holograms/OVD Market in 2014 and 2015
7.3 Pharmaceutical Holograms/OVD Market: Sales Forecast 2016-2026
7.4 Pharmaceutical Holograms/OVD Market: Drivers and Restraints 2016-2026
8. Other Pharmaceutical Anti-Counterfeiting Technologies Market: Sales Forecast 2016-2026
9. National Markets for Pharmaceutical Anti-Counterfeiting Technology, 2016-2026
9.1 Geographical Breakdown of the World Pharmaceutical Anti-Counterfeiting Market in 2014-2015
9.2 World Pharmaceutical Anti-Counterfeiting Technologies Market: National Markets Forecast 2016-2026
9.3 How Will National Market Shares Change by 2026?
9.4 The US Pharmaceutical Anti-Counterfeiting Market
9.4.1 The US Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.4.2 Trends and Developments in the US Pharmaceutical Anti-Counterfeiting Market
9.5 The EU5 Pharmaceutical Anti-Counterfeiting Technologies Market
9.5.1 The EU5 Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.5.2 EU5 Enforcement of Drug Serialisation in 2016
9.6 The Japanese Pharmaceutical Anti-Counterfeiting Market
9.6.1 The Japanese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.6.2 The Uptake of Anti-Counterfeit Technology in Japan
9.7 The Chinese Pharmaceutical Anti-Counterfeiting Market
9.7.1 The Chinese Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.7.2 Chinese Pharmaceutical Anti-Counterfeiting Measures from Past to Present
9.8 The Indian Pharmaceutical Anti-Counterfeiting Market
9.8.1 The Indian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.8.2 India’s Award Winning DAVA Project will Restore
9.9 The Brazilian Pharmaceutical Anti-Counterfeiting Market
9.9.1 The Brazilian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.9.2 Brazilian Anti-Counterfeiting Measures from Past to Present
9.10 The Russian Pharmaceutical Anti-Counterfeiting Market
9.10.1 The Russian Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.10.2 Russia’s New Anti-Counterfeiting Programme Due Q1 2017
9.11 The Mexican Pharmaceutical Anti-Counterfeiting Market
9.11.1 The Mexican Pharmaceutical Anti-Counterfeiting Market Forecast, 2016-2026
9.11.2 Mexico Signs the Anti-Counterfeiting Trade Agreement
10. Pipeline for the Pharmaceutical Anti-Counterfeiting Market
10.1 Breathable Holograms at the University of Michigan
10.2 3D Ingestible Barcodes
10.3 3D Barcodes
10.4 Nanoparticle Ink
10.5 Chipped Pharmaceuticals In Vivo
10.6 Stable Isotope Excipients for Drug Identification
10.7 Agamatrix Diagnostic Strip
11. Leading Companies in the Pharmaceutical Anti-Counterfeit Market
11.1 Leading Pharmaceutical Anti-Counterfeiting Technology Manufacturers by Segment in 2016
11.2 3M Overview
11.2.1 3M Financial Figures
11.3 Alien Technologies Overview
11.3.1 Recent Developments at Alien Technologies
11.4 AlpVision Overview
11.4.1 AlpVision Products
11.4.2 Recent developments at AlpVision
11.5 Angstrom Technologies Overview
11.6 Authentix Overview
11.6.1 Product-Specific Track-and-Trace Solutions
11.6.2 Packaging Solutions
11.7 Avery Dennison Overview
11.7.1 Avery Dennison Financial Figures
11.8 Colorcon Overview
11.8.1 Colorcon’s Taggants: On-Dose ID
11.8.2 Recent Developments for Colorcon
11.9 Covectra Overview
11.9.1 Recent Developments at Covectra
11.10 Everest Holovisions Overview
11.11 Honeywell Acquires Intermec
11.11.1 Honeywell Financial Figures
11.12 Multi Packaging Solutions Overview
11.12.1 MPS Recent Developments
11.13 ThermoFisher Scientific Overview
11.13.1 ThermoFisher Scientific Financial Figures
11.13.2 Recent Developments at ThermoFisher Scientific
11.14 TruTag Technologies Overview
11.14.1 Recent Developments at TruTag Technologies
11.15 UPM Raflatac Overview
11.15.1 UPM Raflatac Recent Developments
11.16 Zebra Technologies Overview
11.16.1 Zebra Technologies Financial Figures
11.16.2 Zebra Technologies Recent Developments
12. Qualitative Analysis of the Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
12.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
12.2 Strengths of the Anti-Counterfeiting Technology Market
12.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
12.2.2 Organisations Promoting Awareness and Implementation of Anti-Counterfeiting Solutions
12.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
12.2.4 New Technologies Providing More Comprehensive Anti-Counterfeiting Protection
12.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
12.3 Weaknesses
12.3.1 Lack of Standardisation Across the Industry Will Impede Technology Adoption
12.3.2 Insufficient Quantitative Measurement of the Effectiveness of Anti-Counterfeiting Technologies
12.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
12.3.4 Lack of Cooperation Between Governmental Organisations Aids Drug Counterfeiters
12.4 Opportunities
12.4.1 Constantly Evolving Technologies Allows for Product Innovation
12.4.2 Anti-Counterfeiting Technologies for the Prevention of Online Fraud
12.5 Threats
12.5.1 High Volume of Counterfeiting Activities Could Devalue Anti-Counterfeiting Solutions
12.5.2 Developing Countries Lack Infrastructure to effectively Deal with Counterfeiting
12.5.3 Rate of Innovation May be Outpaced by Counterfeiters
12.6 STEP Analysis of the World Pharmaceutical Anti-Counterfeiting Technologies Market, 2016-2026
12.7 Social Factors Affecting the Pharmaceutical Anti-Counterfeiting Market
12.7.1 Weak Enforcement of Legislation
12.7.2 Corruption is a Hindrance to Eradicating Pharmaceutical Counterfeiting
12.7.3 Changing Public Perception and Consumer Education
12.7.4 Concerns Over Privacy
12.8 Technological Factors
12.8.1 Smartphone Read and Verify: A Customer Empowerment Tool
12.8.2 US FDA Counterfeit Detection Device
12.8.3 UV and IR Inks Being Used Covertly for Increased Security
12.8.4 Potential Replacements for Barcodes
12.8.5 SigNature DNA
12.9 Economic Factors
12.9.1 Implementation Costs of Anti-Counterfeiting Technologies
12.9.2 Anti-Counterfeiting Technologies Require R&D Investment
12.10 Political Factors
12.10.1 Who: The IMPACT Programme
12.10.2 Interpol Operations
12.10.3 Anti-Counterfeiting Trade Agreement (ACTA)
12.10.4 The Fagan Case: Effects of Litigation on Players in the Drug Supply Chain
12.10.5 Legislations for Supply Chain Security
12.10.6 E-pedigree: Catalyst for Product Serialisation
12.10.7 UK MHRA: Falsified Medical Products Strategy
12.10.8 EU’s Falsified Medicines Directive
13. Research Interview
13.1 Interview with Dr Fred Jordan, CEO of AlpVision
13.1.1 On AlpVision and its Products
13.1.2 On the Problem of Counterfeiting Now and in the Future
13.2 Interview with Dr Jamie Barras, Technical Manager for CONPHIRMER
13.2.1 On the CONPHIRMER Consortium
13.2.2 On the Problem of Counterfeiting Now and in the Future
14. Conclusions
14.1 Pharmaceutical Anti-Counterfeiting Technologies: A Growing Market
14.2 Leading Pharmaceutical Anti-Counterfeiting Technologies Submarkets in 2015-2026
14.3 Leading National Markets in 2015
14.4 The Future of the Pharmaceutical Anti-Counterfeiting Technologies
14.4.1 Government Mandates Will Fuel Growth in the Market
14.4.2 The US Will Continue to Dominate the Market
14.4.3 New Directives Will Ensure track-and-Trace Market Leadership
14.4.4 European Preference for Mandated 2D Barcode Technology
14.4.5 Enhances Regulation of Online Pharmacies Necessary for Anti-Counterfeiting Technologies to be Effective
14.4.6 Market Expansion Will be Dependent on the Development of Industry-wide Standards
14.4.7 What Will Succeed in the Pharmaceutical Anti-Counterfeiting Technologies Market?
Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2014
Table 2.2 Global Reported Incidents of Drug Counterfeiting by Region & Regional Percentage (%), 2014
Table 2.3 Classification of Counterfeit Pharmaceutical Products
Table 2.4 Characteristics of an Ideal Anti-counterfeiting Technology
Table 2.5 Advantages and Disadvantages of Overt and Covert Technologies
Table 2.6 Types of Anti-counterfeiting Technologies Used in the Pharmaceutical Industry by Category
Table 3.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2014 and 2015
Table 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: CAGR (%) by Technology in 2014-2020, 2020-2026 and 2014-2026
Table 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Technology, 2015, 2020 and 2026
Table 4.1 Comparison of 2D Barcode and RFID Technology
Table 4.2 Barcodes Submarket Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 5.1 RFID Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2016-2026
Table 6.1 Taggants Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 7.1 Holograms/OVD Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 8.1 Others Submarket Forecast: Revenues ($m), Market Share (%), AGR (%), CAGR (%), 2016-2026
Table 9.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Region, 2014 and 2015
Table 9.2 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2016-2026
Table 9.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Market Shares (%) by Region, 2015, 2020 and 2026
Table 9.4 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.5 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.6 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.7 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.8 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.9 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.10 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 9.11 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), AGR (%), Market Share (%), CAGR (%), 2016-2026
Table 11.1 Leading RFID Technology Manufacturers, 2016
Table 11.2 Leading Holographic Labelling Technology Manufacturers, 2016
Table 11.3 Leading Taggants Technology Manufacturers, 2016
Table 11.4 Other Leading Anti-counterfeiting Technology Manufacturers, 2016
Table 11.5 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
Table 11.6 3M Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.7 Alien Technologies: Portfolio of RFID Readers, 2016
Table 11.8 Alien Technologies: Portfolio of RFID Inlays and Their Relative Performances in Pharma Applications, 2016
Table 11.9 AlpVision: Portfolio of Pharmaceutical Anti-counterfeiting Solutions, 2016
Table 11.10 Angstrom Technologies: Portfolio of Anti-Counterfeiting Solutions, 2016
Table 11.11 Avery Dennison: Portfolio of RFID Inlays for Use in Pharmaceuticals, 2016
Table 11.12 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2015
Table 11.13 Avery Dennison Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.14 Everest Holovision: Portfolio of Pharma Products and Applications, 2016
Table 11.15 Honeywell’s Intermec: Portfolio of Products and Descriptions, 2016
Table 11.16 Honeywell Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.17 ThermoFisher Scientific Historical Sales: Revenue ($m), AGR (%), 2010-2015
Table 11.18 UPM Raflatac: Portfolio of Product Groups and Descriptions, 2016
Table 11.19 Zebra Technologies Historical Sales: Revenue ($m), AGR (%), 2010-2014
Table 12.1 SWOT Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
Table 12.2 Selected Instances of Counterfeiting Activities, 2011-2016
Table 12.3 STEP Analysis of World Pharmaceutical Anti-counterfeiting Technologies Market, 2016-2026
Figure 1.1 World Anti-counterfeiting Market Segmentation by Technology Overview
Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2009-2014
Figure 2.2 Global Reported Incidents of Drug Counterfeiting by Region, 2014
Figure 2.3 Global Reported Incidents of Drug Counterfeiting by Regional Percentage (%), 2014
Figure 2.4 Most Common Types of Drugs Counterfeited in Developed and Emerging Countries, 2016
Figure 2.5 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 2.6 Basic Components of a RFID System: Antenna, Transceiver and Transponder
Figure 3.1 World Pharmaceutical Anti-Counterfeiting Technologies Market: Revenues ($m) by Technology, 2014
Figure 3.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2015
Figure 3.3 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 3.4 World Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 3.5 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Technology, 2016-2026
Figure 3.6 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2020 and 2020-2026
Figure 3.7 World Pharmaceutical Anti-counterfeiting Market Forecast: CAGR (%) by Technology in 2014-2026
Figure 3.8 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2015
Figure 3.9 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2020
Figure 3.10 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Technology, 2026
Figure 3.11 World Pharmaceutical Anti-counterfeiting Technologies Market: Drivers and Restraints, 2016-2026
Figure 4.1 Barcodes Market Forecast: Revenues ($m), 2016-2026
Figure 4.2 Barcodes Market Forecast: AGR (%), 2016-2026
Figure 4.3 Barcodes Market Forecast: Drivers and Restraints, 2016-2026
Figure 5.1 RFID Market Forecast: Revenues ($m), 2014-2026
Figure 5.2 RFID Market Forecast: AGR (%), 2016-2026
Figure 5.3 RFID Market Forecast: Drivers and Restraints, 2016-2026
Figure 6.1 Taggants Submarket Forecast: Revenues ($m), 2016-2026
Figure 6.2 Taggants Submarket Forecast: AGR (%), 2016-2026
Figure 6.3 Taggants Submarket Forecast: Drivers and Restraints, 2016-2026
Figure 7.1 Holograms/OVD Submarket Forecast: Revenue ($m), 2016-2026
Figure 7.2 Holograms/OVD Submarket Forecast: AGR (%), 2016-2026
Figure 7.3 Holograms/OVD Market Forecast: Drivers and Restraints, 2016-2026
Figure 8.1 Others Submarket Forecast: Revenue ($m), 2016-2026
Figure 8.2 Others Submarket Forecast: AGR ($m), 2016-2026
Figure 9.1 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2014
Figure 9.2 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2015
Figure 9.3 World Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Region, 2016-2026
Figure 9.4 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2015
Figure 9.5 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2020
Figure 9.6 World Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2026
Figure 9.7 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenues ($m), 2016-2026
Figure 9.8 US Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.9 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.10 EU5 Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.11 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.12 Japanese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.13 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.14 Chinese Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.15 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.16 Indian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.17 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.18 Brazilian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.19 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.20 Russian Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 9.21 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: Revenue ($m), 2016-2026
Figure 9.22 Mexican Pharmaceutical Anti-counterfeiting Technologies Market Forecast: AGR (%), 2016-2026
Figure 11.1 3M: Revenue Shares (%) by Business Segment, 2015
Figure 11.2 3M Historical Sales: Revenue ($m), 2010-2015
Figure 11.3 Authentix’s Global Monitoring Service: A Three Step Programme
Figure 11.4 Avery Dennison: Revenue Shares (%) by Business Segment, 2015
Figure 11.5 Avery Dennison Historical Sales: Revenue ($m), 2010-2015
Figure 11.6 Honeywell Historical Sales: Revenue ($m), 2010-2015
Figure 11.7 ThermoFisher Scientific Historical Sales: Revenue ($m), 2010-2015
Figure 11.8 Zebra Technologies Historical Sales: Revenue ($m), 2010-2014
Figure 12.1 EU Supply Chain Authentication Strategy, 2016
Figure 12.2 US Supply Chain Authentication Strategy, 2016
Figure 13.1 Leading Submarkets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026
Figure 13.2 Leading National Markets for the Pharmaceutical Anti-Counterfeiting Technologies Market: Revenue ($m) from 2015-2026
